@kimlockhartga As someone who has worked in the pharma industry: some drugs are more profitable than others. There is little research into rare diseases and also neuropathology because it is risky from a return-on-investment standpoint. I don't know for sure about antidepressants but I can imagine that big pharma will think it's not a huge impact on their bottom line and do nothing 😔